"Normoalbuminuric" diabetic nephropathy: Tubular damage and NGAL

Acta Diabetologica

Volumn 50, Issue 6, 2013, Pages 935-942

  Lacquaniti, Antonio ^a   Donato, Valentina ^a   Pintaudi, Basilio ^a   Di Vieste, Giacoma ^a   Chirico, Valeria ^a   Buemi, Antoine ^a   Di Benedetto, Antonino ^a   Arena, Adriana ^a   Buemi, Michele ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Biomarker; Diabetic nephropathy; NGAL; Tubular damage; Type 1 diabetes mellitus

Indexed keywords

CREATININE; HEMOGLOBIN A1C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; URIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE DISORDER; MALE; MICROALBUMINURIA; NORMOALBUMINURIC DIABETIC NEPHROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ACUTE-PHASE PROTEINS; ADULT; ALBUMINS; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TUBULES; LIPOCALINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; ROC CURVE;

EID: 84890549685     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0485-7     Document Type: Article

References (34)

1. Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195-207
2. Fathy Manal A, Elkady Manal M, Fathy Hanan A, Awad Seham A, Elmenshawy Amal A (2009) Estimation of renal tubular markers for predicting early stage diabetic nephropathy in Egyptian children with type I diabetes mellitus. Res J Med Med Sci 4:207-211
3. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G (2004) Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 27:195-200
4. Thomas MC, Burns WC, Cooper ME (2005) Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12:177-186
5. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373
6. Wolf G (2000) Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 77:59-66
7. Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, Brandis M (1993) Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein. Clin Investig 71:972-977
8. Yaqoob M, McClelland P, Patrick AW et al (1994) Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 87:601-607
9. Dunlop M (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77:S3-S12
10. Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-789
11. Bolignano D, Donato V, Coppolino G et al (2008) Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52:595-605
12. Mishra J, Dent C, Tarabishi R et al (2005) Neutrophil gelatinase-associated lipocalin as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238
13. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S (2006) Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26:287-292
14. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M (2008) Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 31:255-258
15. Bolignano D, Lacquaniti A, Coppolino G et al (2009) Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4:337-344
16. Guo L, Cheng Y, Wang X et al (2012) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol 49:65-71
17. Bolignano D, Coppolino G, Lacquaniti A, Buemi M (2010) From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 40:273-276
18. Bolignano D, Lacquaniti A, Coppolino G et al (2009) Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 32:91-98
19. Zachwieja J, Soltysiak J, Fichna P et al (2009) Normal-range albuminuria does not exclude nephropathy in diabetic children. Pediatr Nephrol 25:51-1445
20. Soggiu A, Piras C, Bonizzi L et al (2012) A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol 49:453-464
21. Phillips AO (2003) The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 3:491-496
22. Mori K, Lee HT, Rapoport D et al (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115:610-621
23. Kuwabara T, Mori K, Mukoyama M et al (2009) Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules and distal nephrons. Kidney Int 75:285-294
24. Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P (2011) Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 79:1113-1118
25. Nielsen SE, Sugaya T, Hovind P, Baba T, Parving HH, Rossing P (2010) Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 33:1320-1324
26. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412
27. Fukuhara M, Matsumura K, Wakisaka M et al (2007) Hyperglycemia promotes microinflammation as evaluated by C-reactive protein in the very elderly. Intern Med 46:207-212
28. Stern MP (1998) The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes. Arch Fam Med 7:155-162
29. Nambi V (2005) The use of myeloperoxidase as a risk marker for atherosclerosis. Curr Atheroscler Rep 7:127-131
30. Elneihoum AM, Falke P, Hedblad B, LindgaÂ̈rde F, Ohlsson K (1997) Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 131:79-84
31. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S (2008) Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology 13:153
32. Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes an inception cohort study. Diabetes 58:1668-1671
33. Mene P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26:2085-2092
34. Siu YP, Leung KT, Tong MKH, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability in lowering serum uric acid level. Am J Kidney Dis 47:51-59